Does "Congressman Fuji" ring a bell? Thatâs the moniker FDA scientists gave to ex-Rep. Christopher Shays (R-CT), who called the agency to express concern about the status of a breast-imaging device made by Connecticut-based Fujifilm Medical Systems, according to internal FDA documents provided to the New York Times. After that phone call, an FDA official ignored agency scientists and approved the device, the documents allege. FDA scientists wrote a letter to President-elect Obama last week alleging a pattern of "corruption" in the FDA division that reviews and approves medical devices. A spokeswoman for that division told ProPublica, "Weâre working directly with the transition team and weâll address their issues directly."
According to the AP, Hillary Clinton acted in the interest of her husbandâs donors at least six times. In one instance, she wrote to the FCC about a rate change she feared would hurt telecoms, citing a New York-based company whose chief executive later donated to her husbandâs foundation.
Thank you for your interest in republishing this story. You are are free republish it so long as you do the following:
You have to credit us — ideally in the byline. We prefer “Author Name, ProPublica.” If your CMS does not allow you to do this, please include a line at the top of the story that reads: “This story was originally published by ProPublica.”
If you’re republishing online, you must link to our website, include all of the links from our story, and use our PixelPing tag.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission (contact our PR Director, Minhee Cho, for more information).
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact our Director of Business Development, Celeste LeCompte.)
You can’t use our work to populate a web site designed to improve rankings on search engines, or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any web site our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica and ProPublica Illinois on both Twitter (@ProPublica and @ProPublicaIL) and Facebook.
Copy and paste the following into your page to republish: